Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
21,664
+2,688
+14% +$179K 0.05% 230
2026
Q1
$1.19M Buy
18,976
+3,858
+26% +$269K 0.08% 214
2025
Q4
$1M Buy
15,118
+913
+6% +$59K 0.08% 234
2025
Q3
$956K Buy
14,205
+2,804
+25% +$222K 0.08% 264
2025
Q2
$995K Sell
11,401
-3,870
-25% -$303K 0.26% 112
2025
Q1
$1.04M Sell
15,271
-13,372
-47% -$1.09M 0.31% 90
2024
Q4
$2.23M Buy
+28,643
New +$2.12M 0.92% 34

Other funds holding DXCM

Tema ETFs's DXCM Position: Q2 2026 in Review

Tema ETFs increased its DexCom (DXCM) stake by 14% in Q2 2026, buying an estimated $179K and bringing the position to 21,664 shares worth $1.46M. The position accounts for 0.05% of the portfolio, ranked #230.

Tema ETFs first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.23M in Q4 2024. 115 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Tema ETFs held 21,664 shares of DexCom worth $1.46M as of Q2 2026.
  • Tema ETFs bought 2,688 DexCom shares in Q2 2026, an estimated $179K.
  • DexCom made up 0.05% of Tema ETFs's portfolio in Q2 2026, its #230 holding.
  • Tema ETFs first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's DexCom position peaked at $2.23M in Q4 2024.
  • 115 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.